$XBI $83.59 | -4.76%
Covid Updates
$OCGN -5.8% Ocugen, Inc. to Commercialize COVAXINâ„¢ in Mexico, Rights Now Encompassing All of North America. source
Pipeline Updates
$ACAD -4.5% Acadia Pharmaceuticals Announces Top-Line Results from Phase 2 Study Evaluating ACP-044 for the Treatment of Acute Postoperative Pain source
$KNTE -5.0% Kinnate Biopharma Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of its FGFR Inhibitor Product Candidate, KIN-3248. source
$BDTX -2.6% Black Diamond Therapeutics Announces First Patient Dosed in Phase 1 Study of BDTX-1535, a MasterKey Inhibitor of EGFR for the Treatment of Glioblastoma and Non-Small Cell Lung Cancer. source
Business Updates
$AFMD -5.7% Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares. source
$TRVN -7.42% Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ex-US Royalty-Based Financing with R-Bridge Healthcare Fund. source
Posted by FS/JM